Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors

Human Molecular Genetics

Volumn 14, Issue SPEC. ISS. 1, 2005, Pages

  Raaphorst, Frank M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCOMB GROUP PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

CARCINOGENESIS; CELL CYCLE; DIAGNOSTIC PROCEDURE; EPITHELIUM TUMOR; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; GENETIC ASSOCIATION; HEMATOLOGIC MALIGNANCY; HUMAN; LYMPHOMA; LYMPHOPOIESIS; MALIGNANT TRANSFORMATION; METABOLIC REGULATION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REVIEW;

CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; CHROMATIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LYMPHOMA; MODELS, GENETIC; NEOPLASMS; REPRESSOR PROTEINS; SKIN NEOPLASMS;

EID: 17444379015     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddi111     Document Type: Review

References (94)

1. Koga, H., Kaji, Y., Nishii, K., Shirai, M., Tomotsune, D., Osugi, T., Sawada, A., Kim, J.Y., Hara, J., Miwa, T. et al. (2002) Overexpression of Polycomb-group gene rae28 in cardiomyocytes does not complement abnormal cardiac morphogenesis in mice lacking rae28 but causes dilated cardiomyopathy. Lab. Invest., 82, 375-385.
2. Caretti, G., Di Padova, M., Micales, B., Lyons, G.E. and Sartorelli, V. (2004) The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev. 18, 2627-2638.
3. Akasaka, T., Kanno, M., Balling, R., Mieza, M.A., Taniguchi, M. and Koseki, H. (1996) A role for mel-18, a Polycomb group-related vertebrate gene, during the anteroposterior specification of the axial skeleton. Development, 122, 1513-1522.
4. Alkema, M.J., van der Lugt, N.M., Bobeldijk, R.C., Berns, A. and van Lohuizen, M. (1995) Transformation of axial skeleton due to overexpression of bmi-1 in transgenic mice. Nature, 374, 724-727.
5. del Mar, L.M., Marcos-Gutierrez, C., Perez, C., Schoorlemmer, J., Ramirez, A., Magin, T. and Vidal, M. (2000) Loss- and gain-of-function mutations show a polycomb group function for Ring1A in mice. Development, 127, 5093-5100.
6. Leung, C., Lingbeek, M., Shakhova, O., Liu, J., Tanger, E., Saremaslani, P., van Lohuizen, M. and Marino, S. (2004) Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature, 428, 337-341.
7. van der Lugt, N.M., Domen, J., Linders, K., van Roon, M., Robanus-Maandag, E., te, R.H., van, D.V., Deschamps, J., Sofroniew, M. and van Lohuizen, M. (1994) Posterior transformation, neurological abnormalities and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev., 8, 757-769.
8. Heard, E. (2004) Recent advances in X-chromosome inactivation. Curr. Opin. Cell Biol., 16, 247-255.
9. Lund, A.H. and van Lohuizen, M. (2004) Polycomb complexes and silencing mechanisms. Curr. Opin. Cell Biol., 16, 239-246.
10. Otte, A.P. and Kwaks, T.H. (2003) Gene repression by Polycomb group protein complexes: a distinct complex for every occasion? Curr. Opin. Genet. Dev., 13, 448-454.
11. Sewalt, R.G., Kwaks, T.H., Hamer, K. and Otte, A.P, (2004) Biochemical analysis of mammalian polycomb group protein complexes and the identification of genetic elements that block polycomb-mediated gene repression. Methods Enzymol., 377, 282-296.
12. Jacobs, J.J. and van Lohuizen, M. (2002) Polycomb repression: from cellular memory to cellular proliferation and cancer. Biochim. Biophys. Acta, 1602, 151-161.
13. Lessard, J. and Sauvageau, G. (2003) Polycomb group genes as epigenetic regulators of normal and leukemic hemopoiesis. Exp. Hematol., 31, 567-585.
14. Attwooll, C., Oddi, S., Cartwright, P., Prosperini, E., Agger, K., Steensgaard, P., Wagener, C., Sardet, C., Moroni, M.C. and Helin, K. (2004) A novel repressive E2F6 complex containing the polycomb group protein, EPC1, that interacts with EZH2 in a proliferation-specific manner. J. Biol. Chem., 280, 1199-1208.
15. Gunster, M.J., Raaphorst, F.M., Hamer, K.M., den Blaauwen, J.L., Fieret, E., Meijer, C.J. and Otte, A.P. (2001) Differential expression of human Polycomb group proteins in various tissues and cell types. J. Cell. Biochem., 81 (Suppl. 36), 129-143.
16. Van Galen, J.C., Dukers, D.F., Giroth, C., Sewalt, R.G., Otte, A.P., Meijer, C.J. and Raaphorst, F.M. (2004) Distinct expression patterns of polycomb oncoproteins and their binding partners during the germinal center reaction. Eur. J. Immunol., 34, 1870-1881.
17. Akasaka, T., Takahashi, N., Suzuki, M., Koseki, H., Bodmer, R. and Koga, H. (2002) MBLR, a new RING finger protein resembling mammalian Polycomb gene products, is regulated by cell cycle-dependent phosphorylation. Genes Cells, 7, 835-850.
18. Sewalt, R.G., Gunster, M.J., van der Vlag, J., Satijn, D.P. and Otte, A.P. (1999) C-terminal binding protein is a transcriptional repressor that interacts with a specific class of vertebrate Polycomb proteins. Mol. Cell. Biol., 19, 777-787.
19. Trimarchi, J.M., Fairchild, B., Wen, J. and Lees, J.A. (2001) The E2F6 transcription factor is a component of the mammalian Bmi1- containing polycomb complex. Proc. Natl Acad. Sci. USA, 98, 1519-1524.
20. Qin, H., Wang, J., Liang, Y., Taniguchi, Y., Tanigaki, K. and Han, H. (2004) RING1 inhibits transactivation of RBP-J by Notch through interaction with LIM protein KyoT2. Nucleic Acids Res., 32, 1492-1501.
21. Garcia, E., Marcos-Gutierrez, C., del Mar, L.M., Moreno, J.C. and Vidal, M. (1999) RYBP, a new repressor protein that interacts with components of the mammalian Polycomb complex and with the transcription factor YY1. EMBO J., 18, 3404-3418.
22. Garcia-Cuellar, M.P., Zilles, O., Schreiner, S.A., Birke, M., Winkler, T.H. and Slany, R.K. (2001) The ENL moiety of the childhood leukemia-associated MLL-ENL oncoprotein recruits human Polycomb 3. Oncogene, 20, 411-419.
23. Soulez, M., Saurin, A.J., Freemont, P.S. and Knight, J.C. (1999) SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co- localize with the human Polycomb group complex. Oncogene, 18 2739-2746.
24. Voncken, J.W., Niessen, H., Neufeld, B., Rennefahrt, U., Dahlmans, V., Kubben, N., Holzer, B., Ludwig, S. and Rapp, U.R. (2004) MAPKAP kinase 3pK phosphorylates and regulates chromatin-association of the polycomb-group protein Bmi1. J. Biol. Chem., 280, 5178-5187.
25. Strahl, B.D. and Allis, C.D. (2000) The language of covalent histone modifications. Nature, 403, 41-45.
26. van der Vlag, J. and Otte, A.P. (1999) Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nat. Genet., 23, 474-478.
27. Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R.S. and Zhang, Y. (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science, 298, 1039-1043.
28. Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P. and Reinberg, D. (2002) Histone methyltransferase activity associated with a human multiprotein complex containing the enhancer of Zeste protein. Genes Dev., 16, 2893-2905.
29. Kuzmichev, A., Jenuwein, T., Tempst, P. and Reinberg, D. (2004) Different ezh2-containing complexes target methylation of histone h1 or nucleosomal histone h3. Mol. Cell, 14, 183-193.
30. Kagey, M.H., Melhuish, T.A., Powers, S.E. and Wotton, D. (2005) Multiple activities contribute to Pc2 E3 function. EMBO J., 24, 108-119.
31. Sewalt, R.G., Lachner, M., Vargas, M., Hamer, K.M., den Blaauwen, J.L., Hendrix, T., Melcher, M., Schweizer, D., Jenuwein, T. and Otte, A.P. (2002) Selective interactions between vertebrate Polycomb homologs and the SUV39H1 histone lysine methyltransferase suggest that histone H3-K9 methylation contributes to chromosomal targeting of Polycomb group proteins. Mol. Cell. Biol., 22, 5539-5553.
32. Fang, J., Chen, T., Chadwick, B., Li, E. and Zhang, Y. (2004) Ring1b-mediated H2A ubiquitination associates with inactive X chromosomes and is involved in initiation of X inactivation. J. Biol. Chem., 279, 52812-52815.
33. Wang, H., Wang, L., Erdjument-Bromage, H., Vidal, M., Tempst, P., Jones, R.S. and Zhang, Y. (2004) Role of histone H2A ubiquitination in Polycomb silencing. Nature, 431, 873-878.
34. de Napoles, M., Mermoud, J.E., Wakao, R., Tang, Y.A., Endoh, M., Appanah, R., Nesterova, T.B., Silva, J., Otte, A.P., Vidal, M., Koseki, H. and Brockdorff, N. (2004) Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation. Dev. Cell, 7, 663-676.
35. Muller, J., Hart, C.M., Francis, N.J., Vargas, M.L., Sengupta, A., Wild, B., Miller, E.L., O'Connor, M.B., Kingston, R.E. and Simon, J.A. (2002) Histone methyltransferase activity of a Drosophila Polycomb group repressor complex. Cell, 111, 197-208.
36. Czermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A. and Pirrotta, V. (2002) Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites. Cell, 111, 185-196.
37. Tie, F., Furayama, T., Prasad-Sinha, J., Jane, E. and Harte, P.J. (2001) The Drosophila Polycomb group proteins ESC and E(Z) are present in a complex containing the histone-binding protein p55 and the histone deacetylase RPD3. Development, 128, 275-286.
38. Furayama, T., Banerjee, R., Breen, T.R. and Harte, P.J. (2004) SIR2 is required for polycomb silencing and is associated with an E(Z) histone methyltransferase complex. Curr. Biol., 14, 1812-1821.
39. Kirmizis, A., Bartley, S.M., Kuzmichev, A., Margueron, R., Reinberg, D., Green, R. and Farnham, P.J. (2004) Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev., 18, 1592-1605.
40. Breiling, A., O'Neill, L.P., D'Eliseo, D., Turner, B.M. and Orlando, V. (2004) Epigenome changes in active and inactive polycomb-group-controlled regions. EMBO Rep., 5, 976-982.
41. Ringrose, L., Ehret, H. and Paro, R. (2004) Distinct contributions of histone H3 lysine 9 and 27 methylation to locus-specific stability of polycomb complexes. Mol. Cell, 16, 641-653.
42. Pasini, D., Bracken, A.P., Jensen, M.R., Denchi, E.L. and Helin, K. (2004) Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J., 23, 4061-4071.
43. Poux, S., Melfi, R. and Pirrotta, V. (2001) Establishment of Polycomb silencing requires a transient interaction between PC and ESC. Genes Dev., 15, 2509-2514.
44. Haupt, Y., Bath, M.L., Harris, A.W. and Adams, J.M. (1993) bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis. Oncogene, 8, 3161-3164.
45. van Lohuizen, M., Verbeek, S., Scheijen, B., Wientjens, E., van der, G.H. and Berns, A. (1991) Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell, 65, 737-752.
46. Haupt, Y., Alexander, W.S., Barri, G., Klinken, S.P. and Adams, J.M. (1991) Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell, 65, 753-763.
47. Jacobs, J.J., Scheijen, B., Voncken, J.W., Kieboom, K., Berns, A. and van Lohuizen, M. (1999) Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc- induced apoptosis via INK4a/ARF. Genes Dev., 13, 2678-2690.
48. Jacobs, J.J., Kieboom, K., Marino, S., DePinho, R.A. and van Lohuizen, M. (1999) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature, 397, 164-168.
49. Kleer, C.G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S.A., Ghosh, D., Sewalt, R.G., Otte, A.P., Hayes, D.F. et al. (2003) EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl Acad. Sci. USA, 100, 11606-11611.
50. Bracken, A.P., Pasini, D., Capra, M., Prosperini, E., Colli, E. and Helin, K. (2003) EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J., 22 5323-5335.
51. Tang, X., Milyavsky, M., Shats, I., Erez, N., Goldfinger, N. and Rotter, V. (2004) Activated p53 suppresses the histone methyltransferase EZH2 gene. Oncogene, 23, 5759-5769.
52. Itahana, K., Zou, Y., Itahana, Y., Martinez, J.L., Beausejour, C., Jacobs, J.J., van Lohuizen, M., Band, V., Campisi, J. and Dimri, G.P. (2003) Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol. Cell. Biol. 23, 389-401.
53. Dimri, G.P., Martinez, J.L., Jacobs, J.J., Keblusek, P., Itahana, K., van Lohuizen, M., Campisi, J., Wazer, D.E. and Band, V. (2002) The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res., 62, 4736-4745.
54. van Kemenade, F.J., Raaphorst, F.M., Blokzijl, T., Fieret, E., Hamer, K.M., Satijn, D.P., Otte, A.P. and Meijer, C.J. (2001) Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood, 97, 3896-3901.
55. Raaphorst, F.M., Vermeer, M., Fieret, E., Blokzijl, T., Dukers, D., Sewalt, R.G., Otte, A.P., Willemze, R. and Meijer, C.J. (2004) Site-specific expression of Polycomb-group genes encoding the HPC-HPH/PRC1 complex in clinically defined primary nodal and cutaneous large B-cell lymphomas. Am. J. Pathol., 164, 533-542.
56. Visser, H.P., Gunster, M.J., Kluin-Nelemans, H.C., Manders, E.M., Raaphorst, F.M., Meijer, C.J., Willemze, R. and Otte, A.P. (2001) The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma. Br. J. Haematol., 112, 950-958.
57. Bea, S., Tort, F., Pinyol, M., Puig, X., Hernandez, L., Hernandez, S., Fernandez, P.L., van Lohuizen, M., Colomer, D. and Campo, E. (2001) BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res., 61, 2409-2412.
58. Dukers, D.F., Van Galen, J.C., Giroth, C., Jansen, P., Sewalt, R.G., Otte, A.P., Kluin-Nelemans, H.C., Meijer, C.J. and Raaphorst, F.M. (2004) Unique Polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines. Am. J. Pathol., 164, 873-881.
59. Raaphorst, F.M., van Kemenade, F.J., Blokzijl, T., Fieret, E., Hamer, K.M., Satijn, D.P., Otte, A.P. and Meijer, C.J. (2000) Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease. Am. J. Pathol., 157, 709-715.
60. Sanchez-Beato, M., Sanchez, E., Garcia, J.F., Perez-Rosado, A., Montoya, M.C., Fraga, M., Artiga, M.J., Navarrete, M., Abraira, V., Morente, M. et al. (2004) Abnormal PcG protein expression in Hodgkin's lymphoma. Relation with E2F6 and NFkappaB transcription factors. J. Pathol., 204, 528-537.
61. Raaphorst, F.M., Otte, A.P., van Kemenade, F.J., Blokzijl, T., Fieret, E., Hamer, K.M., Satijn, D.P. and Meijer, C.J. (2001) Distinct bmi-1 and ezh2 expression patterns in thymocytes and mature t cells suggest a role for polycomb genes in human t cell differentiation. J. Immunol., 166, 5925-5934.
62. Raaphorst, F.M., van Kemenade, F.J., Fieret, E., Hamer, K.M., Satijn, D.P., Otte, A.P. and Meijer, C.J. (2000) Cutting edge: polycomb gene expression patterns reflect distinct B cell differentiation stages in human germinal centers. J. Immunol., 164, 1-4.
63. Grange, F., Bekkenk, M.W., Wechsler, J., Meijer, C.J., Cerroni, L., Bernengo, M., Bosq, J., Hedelin, G., Fink, P.R., van Vloten, W.A. et al. (2001) Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study. J. Clin. Oncol., 19, 3602-3610.
64. Rijlaarsdam, J.U., Toonstra, J., Meijer, O.W., Noordijk, E.M. and Willemze, R. (1996) Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. J. Clin. Oncol., 14, 549-555.
65. Pandolfino, T.L., Siegel, R.S., Kuzel, T.M., Rosen, S.T. and Guitart, J. (2000) Primary cutaneous B-cell lymphoma: review and current concepts. J. Clin. Oncol., 18, 2152-2168.
66. Vermeer, M.H., Geelen, F.A., van Haselen, C.W., Voorst Vader, P.C., Geerts, M.L., van Vloten, W.A. and Willemze, R. (1996) Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group. Arch. Dermatol., 132, 1304-1308.
67. de Boer, W.P., Oudejans, J.J., Meijer, C.J. and Lankelma, J. (2003) Analysing gene expressions with GRANK. Bioinformatics., 19, 2000-2001.
68. Taniguchi, T., Chikatsu, N., Takahashi, S., Fujita, A., Uchimaru, K., Asano, S., Fujita, T. and Motokura, T. (1999) Expression of p16INK4A and p14ARF in hematological malignancies. Leukemia, 13 1760-1769.
69. Berns, K., Hijmans, E.M., Mullenders, J., Brummelkamp, T.R., Velds, A., Heimerikx, M., Kerkhoven, R.M., Madiredjo, M., Nijkamp, W., Weigelt, B. et al. (2004) A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature, 428, 431-437.
70. Satijn, D.P., Olson, D.J., van der Vlag, J., Hamer, K.M., Lambrechts, C., Masselink, H., Gunster, M.J., Sewalt, R.G., van Driel, R. and Otte, A.P. (1997) Interference with the expression of a novel human polycomb protein, hPc2, results in cellular transformation and apoptosis. Mol. Cell. Biol., 17, 6076-6086.
71. Kanno, M., Hasegawa, M., Ishida, A., Isono, K. and Taniguchi, M. (1995) mel-18, a Polycomb group-related mammalian gene, encodes a transcriptional negative regulator with tumor suppressive activity. EMBO J., 14, 5672-5678.
72. Dahiya, A., Wong, S., Gonzalo, S., Gavin, M. and Dean, D.C. (2001) Linking the rb and polycomb pathways. Mol. Cell, 8, 557-569.
73. Neo, S.Y., Leow, C.K., Vega, V.B., Long, P.M., Islam, A.F., Lai, P.B., Liu, E.T. and Ren, E.C. (2004) Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach. Hepatology, 39, 944-953.
74. Wang, S., Robertson, G.P. and Zhu, J. (2004) A novel human homologue of Drosophila polycomblike gene is up-regulated in multiple cancers. Gene, 343, 69-78.
75. Raaphorst, F.M., Meijer, C.J., Fieret, E., Blokzijl, T., Mommers, E., Buerger, H., Packeisen, J., Sewalt, R.A., Otte, A.P. and van Diest, P.J. (2003) Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene. Neoplasia, 5, 481-488.
76. Clark, J., Edwards, S., John, M., Flohr, P., Gordon, T., Maillard, K., Giddings, I., Brown, C., Bagherzadeh, A., Campbell, C. et al. (2002) Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones. Genes Chromosomes. Cancer, 34, 104-114.
77. Vonlanthen, S., Heighway, J., Altermatt, H.J., Gugger, M., Kappeler, A., Borner, M.M., Lohuizen, M. and Betticher, D.C. (2001) The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br. J. Cancer 84, 1372-1376.
78. Ferreux, E., Lont, A.P., Horenblas, S., Gallee, M.P., Raaphorst, F.M., Von Knebel, D.M., Meijer, C.J. and Snijders, P.J. (2003) Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J. Pathol., 201, 109-118.
79. Varambally, S., Dhanasekaran, S.M., Zhou, M., Barrette, T.R., Kumar-Sinha, C., Sanda, M.G., Ghosh, D., Pienta, K.J., Sewalt, R.G., Otte, A.P., Rubin, M.A. and Chinnaiyan, A.M. (2002) The polycomb group protein EZH2 is involved in progession of prostate cancer. Nature, 419, 624-629.
80. Breuer, R.H., Snijders, P.J., Smit, E.F., Sutedja, T.G., Sewalt, R.G., Otte, A.P., van Kemenade, F.J., Postmus, P.E., Meijer, C.J. and Raaphorst, F.M. (2005) Increased expression of the EZH2 Polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis. Neoplasia, 6, 736-743.
81. Kim, J.H., Yoon, S.Y., Kim, C.N., Joo, J.H., Moon, S.K., Choe, I.S., Choe, Y.K. and Kim, J.W. (2004) The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett., 203, 217-224.
82. Kim, J.H., Yoon, S.Y., Jeong, S.H., Kim, S.Y., Moon, S.K., Joo, J.H., Lee, Y., Choe, I.S. and Kim, J.W. (2004) Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast, 13, 383-388.
83. LaTulippe, E., Satagopan, J., Smith, A., Scher, H., Scardino, P., Reuter, V. and Gerald, W.L. (2002) Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res., 62, 4499-4506.
84. Lapointe, J., Li, C., Higgins, J.P., van de, R.M., Bair, E., Montgomery, K., Ferrari, M., Egevad, L., Rayford, W., Bergerheim, U. et al. (2004) Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc. Natl Acad. Sci. USA, 101, 811-816.
85. Adib, T.R., Henderson, S., Perrett, C., Hewitt, D., Bourmpoulia, D., Ledermann, J. and Boshoff, C. (2004) Predicting biomarkers for ovarian cancer using gene-expression microarrays. Br. J. Cancer, 90, 686-692.
86. Sellers, W.R. and Loda, M. (2002) The EZH2 polycomb transcriptional repressor-a marker or mover of metastatic prostate cancer? Cancer Cell, 2, 349-350.
87. Nakao, M., Minami, T., Ueda, Y., Sakamoto, Y. and Ichimura, T. (2004) Epigenetic system: a pathway to malignancies and a therapeutic target. Int. J. Hematol., 80, 103-107.
88. Egger, G., Liang, G., Aparicio, A. and Jones, P.A. (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature, 429, 457-463.
89. Katoh, M. and Katoh, M. (2003) Identification and characterization of ASXL2 gene in silico. Int. J. Oncol., 23, 845-850.
90. Fisher, C.L., Berger, J., Randazzo, F. and Brock, H.W. (2003) A human homolog of Additional sex combs, ADDITIONAL SEX COMBS-LIKE 1, maps to chromosome 20q11. Gene, 306, 115-126.
91. Bench, A.J., Li, J., Huntly, B.J., Delabesse, E., Fourouclas, N., Hunt, A.R., Deloukas, P. and Green, A.R. (2004) Characterization of the imprinted polycomb gene L3MBTL, a candidate 20q tamour suppressor gene, in patients with myeloid malignancies. Br. J. Haematol., 127, 509-518.
92. Sugimura, T. and Ushijima, T. (2000) Genetic and epigenetic alterations in carcinogenesis. Mutat. Res., 462, 235-246.
93. Valk-Lingbeek, M.E., Bruggeman, S.W. and van Lohuizen, M. (2004) Stem cells and cancer; the polycomb connection. Cell, 118 409-418.
94. Raaphorst, F.M. (2003) Self-renewal of hematopoietic and leukemic stem cells: a central role for the Polycomb-group gene Bmi-1. Trends Immunol., 24, 522-524.